Download PDF
CC BY 4.0 · J Neuroanaesth Crit Care
DOI: 10.1055/s-0044-1786178
Case Report

A Case of Spontaneous Intracranial Hematoma with Critically Low Platelet Count: A Neurointensivist's Nightmare

Sukhen Samanta
1   Critical Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
,
Malligere Prasanna
1   Critical Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Complications of immune thrombocytopenia (ITP) are more frequent at a platelet count lower than 10,000/μL of blood. Intracranial hematoma (ICH) is one of the most severe complications of ITP. Subdural hematoma (SDH) and subarachnoid hemorrhage (SAH) usually occur as extensions of ICH and is generally spontaneous in nature. We report a case of ICH along with SDH and SAH who presented with critically low platelet count managed using apheresis platelet transfusion, desmopressin, intravenous immunoglobulin, and methylprednisolone. The patient was discharged successfully from hospital without any neurological deficit. The importance of early referral and immediate aggressive management and monitoring at an advanced center is suggested.

Keywords

immune thrombocytopenia - intracranial hematoma - critically low platelet counts


Publication History

Article published online:
07 May 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Neunert C, Noroozi N, Norman G. et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost 2015; 13 (03) 457-464
    CrossrefPubMedGoogle Scholar
  • 2 Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood 2009; 113 (26) 6511-6521
    CrossrefPubMedGoogle Scholar
  • 3 Zhao P, Hou M, Liu Y. et al. Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age. Platelets 2021; 32 (05) 633-641
    CrossrefPubMedGoogle Scholar
  • 4 Panicker JN, Pavithran K, Thomas M. Management of subdural hematoma in immune thrombocytopenic purpura: report of seven patients and a literature review. Clin Neurol Neurosurg 2009; 111 (02) 189-192
    CrossrefPubMedGoogle Scholar
  • 5 Lee MS, Kim WC. Intracranial hemorrhage associated with idiopathic thrombocytopenic purpura: report of seven patients and a meta-analysis. Neurology 1998; 50 (04) 1160-1163
    CrossrefPubMedGoogle Scholar
  • 6 Frontera JA, Lewin III JJ, Rabinstein AA. et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: executive summary. A statement for healthcare professionals from the Neurocritical Care Society and the Society of Critical Care Medicine. Crit Care Med 2016; 44 (12) 2251-2257
    CrossrefPubMedGoogle Scholar
  • 7 Rangel-Castilla L, Gopinath S, Robertson CS. Management of intracranial hypertension. Neurol Clin 2008; 26 (02) 521-541 , x
    CrossrefPubMedGoogle Scholar
  • 8 Kurata Y, Miyagawa S, Kosugi S. et al. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura. Thromb Haemost 1994; 71 (02) 184-187
    PubMedGoogle Scholar
  • 9 Neunert CE, Cooper N. Evidence-based management of immune thrombocytopenia: ASH guideline update. Hematology (Am Soc Hematol Educ Program) 2018; 2018 (01) 568-575
    CrossrefPubMedGoogle Scholar
  • 10 Gellens R, Habchi S, Freppel S, Couret D, Iacobelli S. Romiplostim for emergency management of severe thrombocytopenia with intracerebral hemorrhage. Front Neurol 2018; 8: 737
    CrossrefPubMedGoogle Scholar